HRP20220401T3 - Nova vizualizacijska sredstva za detektiranje neurološke disfunkcije - Google Patents

Nova vizualizacijska sredstva za detektiranje neurološke disfunkcije

Info

Publication number
HRP20220401T3
HRP20220401T3 HRP20220401TT HRP20220401T HRP20220401T3 HR P20220401 T3 HRP20220401 T3 HR P20220401T3 HR P20220401T T HRP20220401T T HR P20220401TT HR P20220401 T HRP20220401 T HR P20220401T HR P20220401 T3 HRP20220401 T3 HR P20220401T3
Authority
HR
Croatia
Prior art keywords
imaging agents
neurological dysfunction
novel imaging
detecting neurological
detecting
Prior art date
Application number
HRP20220401TT
Other languages
English (en)
Inventor
Hartmuth C. Kolb
Joseph C. Walsh
Qianwa Liang
Brian A. Duclos
Wei Zhang
Peter J.H. Scott
Kai Chen
Zhiyong Gao
Tieming Zhao
Vani P. Mocharla
Dhanalakshmi Kasi
Gang Chen
Eric Wang
Anjana Sinha
Chunfang Xia
Henry Clifton Padgett
Farhad Karimi
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40627498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20220401(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HRP20220401T3 publication Critical patent/HRP20220401T3/hr
Publication of HRP20220401T4 publication Critical patent/HRP20220401T4/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
HRP20220401TT 2008-02-14 2009-02-17 Nova vizualizacijska sredstva za detektiranje neurološke disfunkcije HRP20220401T4 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6610108P 2008-02-14 2008-02-14
EP09711194.2A EP2247558B2 (en) 2008-02-14 2009-02-17 Novel imaging agents for detecting neurological dysfunction
PCT/US2009/000961 WO2009102498A1 (en) 2008-02-14 2009-02-17 Novel imaging agents for detecting neurological dysfunction

Publications (2)

Publication Number Publication Date
HRP20220401T3 true HRP20220401T3 (hr) 2022-05-27
HRP20220401T4 HRP20220401T4 (hr) 2024-09-27

Family

ID=40627498

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20220401TT HRP20220401T4 (hr) 2008-02-14 2009-02-17 Nova vizualizacijska sredstva za detektiranje neurološke disfunkcije

Country Status (16)

Country Link
US (2) US20110046378A1 (hr)
EP (2) EP2599763A1 (hr)
JP (1) JP2011512354A (hr)
KR (1) KR20100135235A (hr)
CA (1) CA2715390A1 (hr)
CY (1) CY1125258T1 (hr)
DK (1) DK2247558T4 (hr)
ES (1) ES2907992T5 (hr)
FI (1) FI2247558T4 (hr)
HR (1) HRP20220401T4 (hr)
HU (1) HUE058352T2 (hr)
LT (1) LT2247558T (hr)
PL (1) PL2247558T5 (hr)
PT (1) PT2247558T (hr)
SI (1) SI2247558T2 (hr)
WO (1) WO2009102498A1 (hr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932557B2 (en) 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
FI2247558T4 (fi) 2008-02-14 2024-09-19 Lilly Co Eli Uusia kuvantamisaineita neurologisen toimintahäiriön toteamiseen
AU2009279172A1 (en) * 2008-08-08 2010-02-11 Neurosearch A/S Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
US9839699B2 (en) * 2008-09-18 2017-12-12 Yeda Research And Development Co., Ltd. Optical method for detecting Alzheimer's disease by systemic administration of curcumin
US8691187B2 (en) * 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
GB201016038D0 (en) 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
JP5928901B2 (ja) * 2010-10-29 2016-06-01 クリノ株式会社 タウイメージングプローブ
WO2013020184A1 (en) * 2011-08-11 2013-02-14 Neuprotect Pty Ltd Flavonoid compounds, and methods of use thereof
US20130315825A1 (en) * 2012-05-03 2013-11-28 Washington University Tricyclic heteroaromatic compounds as alpha-synuclein ligands
CN104781234A (zh) * 2012-05-22 2015-07-15 伊莱利利公司 用于检测神经功能障碍的基于咔啉和咔唑的成像剂
SG11201504901PA (en) 2012-12-21 2015-07-30 Nat Inst Radiolog Novel compound for imaging tau protein accumulated in the brain
WO2014194169A1 (en) 2013-05-31 2014-12-04 The General Hospital Corporation Radiosynthesis of tau radiopharmaceuticals
UY35625A (es) 2013-06-25 2014-12-31 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Compuestos de tetrahidrocarbazol y carbazol carboxamida sustituidos como inhibidores de quinasa
WO2014210087A1 (en) 2013-06-25 2014-12-31 Bristol-Myers Squibb Company Carbazole carboxamide compounds useful as kinase inhibitors
TWI513698B (zh) * 2013-10-08 2015-12-21 Hoffmann La Roche 做為ｔａｕ－ｐｅｔ－配位體之二氮雜咔唑衍生物
TWI667233B (zh) 2013-12-19 2019-08-01 德商拜耳製藥公司 新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
US10662193B2 (en) 2014-01-21 2020-05-26 Ac Immune Sa Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins
KR102530129B1 (ko) 2014-05-13 2023-05-10 에프. 호프만-라 로슈 아게 중수소화된 헤테로사이클릭 화합물 및 이의 조영제로서의 용도
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
JP6782227B2 (ja) * 2014-09-05 2020-11-11 ザ・ジョンズ・ホプキンス・ユニバーシティー ＣａＭＫＩＩ阻害剤及びその使用
LT3461821T (lt) 2014-10-24 2020-08-10 Bristol-Myers Squibb Company Indolo karboksamido junginiai, naudotini kaip kinazės inhibitoriai
LT3209651T (lt) 2014-10-24 2020-01-10 Bristol-Myers Squibb Company Karbazolo dariniai
JP6592512B2 (ja) 2014-10-24 2019-10-16 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 三環式アトロプ異性体の化合物
CN107207508B (zh) 2015-02-02 2020-02-28 Ucb生物制药私人有限公司 9h-吡咯并-二吡啶衍生物
CN105566269B (zh) * 2015-03-27 2018-07-10 北京大学 香豆素衍生物的制备、药理作用及治疗瘙痒的应用
CN105524034B (zh) * 2015-03-27 2018-08-17 北京大学 香豆素衍生物的制备、药理作用及治疗脑缺血的应用
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
EP3322707A1 (en) 2015-07-15 2018-05-23 AC Immune SA Novel imaging compounds
EP3118202A1 (en) 2015-07-15 2017-01-18 AC Immune S.A. Dihydropyridopyrrole derivatives as tau-pet-ligands
AU2016351609B2 (en) 2015-11-13 2019-08-08 Eli Lilly And Company Azetidine derivatives for tau imaging
CA3010690A1 (en) * 2016-02-03 2017-08-10 Janssen Pharmaceutica Nv Tau pet imaging ligands
US10865207B2 (en) 2016-07-22 2020-12-15 Ac Immune S.A. Compounds for imaging Tau protein aggregates
MX386900B (es) * 2016-07-22 2025-03-19 Ac Immune S A Star Compuestos para formacion de imagenes de agregados de proteinas tau.
WO2018024642A1 (en) 2016-08-02 2018-02-08 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
WO2018024643A1 (en) 2016-08-02 2018-02-08 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
MX375720B (es) 2016-09-09 2025-03-04 Hoffmann La Roche Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol.
TW201906818A (zh) 2017-05-31 2019-02-16 美商５１１製藥公司 新穎氘取代之正子發射斷層掃描（ｐｅｔ）顯影劑及其藥理應用
EP3743426A1 (en) 2018-01-24 2020-12-02 AC Immune SA Azacarboline compounds for the detection of tau aggregates
US11306089B2 (en) 2018-01-24 2022-04-19 Life Molecular Imaging Limited Gamma-carboline compounds for the detection of Tau aggregates
JPWO2019168170A1 (ja) * 2018-03-02 2021-03-04 国立大学法人 長崎大学 クロモン誘導体及びアミロイド関連疾患診断用組成物
CN112384517B (zh) 2018-05-09 2023-07-14 新旭生技股份有限公司 杂芳基化合物及其用途
WO2021055670A1 (en) 2019-09-20 2021-03-25 Avx Corporation Somatic cell-based electrical biosensor
CA3161455A1 (en) 2019-11-13 2021-05-20 Aprinoia Therapeutics Limited Compounds for degrading tau protein aggregates and uses thereof
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
US20240368106A1 (en) * 2021-08-30 2024-11-07 Pretzel Therapeutics, Inc. Hydroxy and alkoxy coumarins as modulators of polrmt
WO2023034346A1 (en) * 2021-08-30 2023-03-09 Pretzel Therapeutics, Inc. Chromen-2-one modulators of polrmt
US11938127B2 (en) 2021-09-28 2024-03-26 Wayne State University Methods and compositions relating to steroid hormone receptor-dependent proliferative disorders
CA3237199A1 (en) 2021-11-02 2023-05-11 Flare Therapeutics Inc. Pparg inverse agonists and uses thereof
WO2023204967A1 (en) * 2022-04-21 2023-10-26 Virginia Commonwealth University Nlrp3 inflammasome inhibitors and compositions and uses thereof
TW202404969A (zh) 2022-04-22 2024-02-01 美商維泰克斯製藥公司 用於治療疼痛之雜芳基化合物
EP4658651A1 (en) 2023-02-02 2025-12-10 Eli Lilly and Company Novel compounds for tau imaging
WO2025155625A1 (en) 2024-01-16 2025-07-24 Eli Lilly And Company Novel compounds for tau imaging

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014477A1 (en) * 1992-12-21 1994-07-07 Mallinckrodt Medical, Inc. Polyhydric phenol compounds
US5871934A (en) * 1993-09-17 1999-02-16 Smithkline Beecham Corporation Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins
US6417178B1 (en) † 1994-07-19 2002-07-09 University Of Pittsburgh Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
EP0859642A2 (en) 1995-10-17 1998-08-26 G.D. Searle & Co. Method of detecting cyclooxygenase-2
JPH09165378A (ja) 1995-12-15 1997-06-24 Seitai Kinou Kenkyusho:Kk Ｎ１−［１８ｆ］フルオロベンジル複素環化合物およびそれらの製造法
ZA989365B (en) † 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
JP2001048786A (ja) 1999-08-05 2001-02-20 Yamanouchi Pharmaceut Co Ltd 三環式ヘテロアリール誘導体
US20020115717A1 (en) † 2000-07-25 2002-08-22 Francine Gervais Amyloid targeting imaging agents and uses thereof
CA2444214A1 (en) 2001-04-23 2002-10-31 The Trustees Of The University Of Pennsylvania Amyloid plaque aggregation inhibitors and diagnostic imaging agents
EP1432453B1 (en) * 2001-08-27 2013-08-14 The Trustees of The University of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
JP2005504053A (ja) † 2001-08-31 2005-02-10 ニューロケム （インターナショナル） リミテッド アミロイドーシス治療のためのアミジン誘導体
EP1442039A1 (en) † 2001-10-31 2004-08-04 Bayer HealthCare AG Pyrimido (4,5-b) indole derivatives
WO2003103598A2 (en) * 2002-06-07 2003-12-18 University Of North Carolina At Chapel Hill Amidine derivatives for treating amyloidosis
CA2503245A1 (en) * 2002-10-24 2004-05-06 Merck & Co., Inc. Alkyne derivatives as tracers for metabotropic glutamate receptor binding
WO2004043496A1 (de) * 2002-11-11 2004-05-27 Austria Wirtschaftsservice Gesellschaft M.B.H. Fluor-18-markierte fluorchinolone
GB0229686D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles
WO2004058764A1 (en) † 2002-12-27 2004-07-15 Bayer Healthcare Ag 4-phenyl-pyrimido [4,5-b] indole derivatives
AU2004249527A1 (en) † 2003-06-23 2004-12-29 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005016888A1 (ja) 2003-08-13 2005-02-24 Bf Research Institute, Inc. アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤
JP2006100537A (ja) 2004-09-29 2006-04-13 Konica Minolta Holdings Inc 有機エレクトロルミネッセンス素子、照明装置及び表示装置
US20060110787A1 (en) * 2004-11-19 2006-05-25 The Board Trustees Of The University Of Arkansas Use of fluorine-18-labeled fluoroquinolone antibiotics for diagnosing and monitoring bacterial infection
JP2007084526A (ja) * 2004-11-26 2007-04-05 Nagasaki Univ アミロイド関連疾患診断用組成物
WO2006057323A1 (ja) * 2004-11-26 2006-06-01 Nagasaki University アミロイド関連疾患診断用組成物
SG194363A1 (en) * 2004-12-17 2013-11-29 Univ Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
FR2885905A1 (fr) † 2005-05-23 2006-11-24 Trophos Sa Nouveaux composes chimiques et leurs utilisations comme medicament
CA2617319A1 (en) * 2005-06-24 2007-01-04 The Trustees Of The University Of Pennsylvania Radiolabeled-pegylation of ligands for use as imaging agents
WO2007014467A1 (en) * 2005-08-03 2007-02-08 Centre For Addiction And Mental Health DlAGNOSIS AND TREATMENT OF MOOD DISORDERS
GB0523506D0 (en) * 2005-11-18 2005-12-28 Hammersmith Imanet Ltd Novel in vivo imaging compounds
US8518964B2 (en) † 2005-11-22 2013-08-27 Merck Sharp & Dohme Corp. Tricyclic compounds useful as inhibitors of kinases
EP1956013B1 (en) 2005-11-30 2016-04-13 Fujifilm RI Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
AR059356A1 (es) * 2006-02-14 2008-03-26 Astrazeneca Ab Nuevos radioligandos
JP2007223952A (ja) 2006-02-23 2007-09-06 Tohoku Univ アミロイドβ蛋白が蓄積する疾患の画像診断プローブ
EP2023919A4 (en) * 2006-05-08 2010-12-22 Molecular Neuroimaging Llc COMPOUNDS AND AMYLOID PROBES FOR THERAPY AND IMAGING USES
US7678819B2 (en) 2006-12-07 2010-03-16 The Trustees Of The University Of Pennsylvania Acetylene derivatives and their use for binding and imaging amyloid plaques
EP2121692B1 (en) † 2006-12-22 2013-04-10 Incyte Corporation Substituted heterocycles as janus kinase inhibitors
EP1944281A1 (en) 2007-01-09 2008-07-16 Technische Universität München 18F-labeled compounds, method for the preparation and use thereof
BRPI0702640A (pt) * 2007-01-10 2008-08-26 Comissao Nac Energia Nuclear processo de radiomarcação de flavonóides e sua aplicação em diagnóstico in vivo de disfunções cerebrais relacionadas aos sìtios receptores benzodiazepìnicos
EP2144916A4 (en) 2007-04-10 2012-01-04 Univ Pennsylvania PHEN-NAPHTHALENE AND PHEN-CHINOLINE DERIVATIVES AND THEIR USE FOR THE BINDING AND PICTURE OF AMYLOIDER PLAQUE
US20110158907A1 (en) * 2007-04-19 2011-06-30 The Trustees Of The Univeristy Of Pennsylvania Diphenyl-heteroaryl derivatives and their use for binding and imaging amyloid plaques
WO2008132454A1 (en) * 2007-04-26 2008-11-06 Ge Healthcare Limited Carbolines and their use as imaging agents
US8942164B2 (en) 2007-10-22 2015-01-27 Texas Instruments Incorporated Differential CQI for OFDMA systems
JP5322180B2 (ja) 2007-07-04 2013-10-23 国立大学法人東北大学 フッ素およびヒドロキシ基で置換されたアルコキシ基を有するｐｅｔプローブ
WO2009045535A2 (en) 2007-10-04 2009-04-09 Sloan-Kettering Institute For Cancer Research Fluorine-18 derivative of dasatinib and uses thereof
FI2247558T4 (fi) 2008-02-14 2024-09-19 Lilly Co Eli Uusia kuvantamisaineita neurologisen toimintahäiriön toteamiseen
KR20110046503A (ko) 2008-07-24 2011-05-04 지멘스 메디컬 솔루션즈 유에스에이, 인크. Ａｄ 병인을 확인하기에 유용한 영상화제
JP2012051804A (ja) 2008-12-26 2012-03-15 Kyoto Univ Ｅｇ５阻害剤
EP2218464A1 (en) 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
TWI513698B (zh) 2013-10-08 2015-12-21 Hoffmann La Roche 做為ｔａｕ－ｐｅｔ－配位體之二氮雜咔唑衍生物
CN107207508B (zh) 2015-02-02 2020-02-28 Ucb生物制药私人有限公司 9h-吡咯并-二吡啶衍生物

Also Published As

Publication number Publication date
US8318132B2 (en) 2012-11-27
DK2247558T3 (da) 2022-02-21
LT2247558T (lt) 2022-04-11
PL2247558T5 (pl) 2024-10-14
CA2715390A1 (en) 2009-08-20
PT2247558T (pt) 2022-03-21
EP2247558B1 (en) 2022-02-02
ES2907992T3 (es) 2022-04-27
ES2907992T5 (en) 2025-03-19
WO2009102498A1 (en) 2009-08-20
EP2599763A1 (en) 2013-06-05
SI2247558T1 (sl) 2022-07-29
SI2247558T2 (sl) 2024-10-30
EP2247558A1 (en) 2010-11-10
KR20100135235A (ko) 2010-12-24
US20110046378A1 (en) 2011-02-24
PL2247558T3 (pl) 2022-05-02
JP2011512354A (ja) 2011-04-21
HRP20220401T4 (hr) 2024-09-27
DK2247558T4 (da) 2024-07-29
EP2247558B2 (en) 2024-07-03
FI2247558T4 (fi) 2024-09-19
HUE058352T2 (hu) 2022-07-28
US20110091382A1 (en) 2011-04-21
CY1125258T1 (el) 2024-02-16

Similar Documents

Publication Publication Date Title
SI2247558T2 (sl) Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij
SG10201706428XA (en) Charge-balanced imaging agents
GB2458223B (en) Imaging device
PT2345175E (pt) Configuração de sinal de referência para lte avançado
IL212550A0 (en) Apj receptor compounds
IL212551A0 (en) Cxcr4 receptor compounds
GB0712682D0 (en) Phantom for imaging apparatuses
GB0610395D0 (en) Novel imaging agents
PL2313364T3 (pl) Sposoby wykrywania symetrycznej dimetyloargininy
GB2448479B (en) Improved shim for imaging magnets
GB0808878D0 (en) Seismic imaging
IL200566A0 (en) Imaging probes
EP2352277A4 (en) IMAGING DEVICE
GB0818738D0 (en) Imaging neuroflammation
GB0717365D0 (en) Imaging
TWI372310B (en) Imaging device
GB0818151D0 (en) Imaging techniques
ZA201005130B (en) N-alkoxyamide conjugates as imaging agents
GB0722650D0 (en) Novel imaging method
GB0803729D0 (en) Imaging the central nervous system
GB0821433D0 (en) Imaging Agents
GB0817044D0 (en) Imaging agents
GB0809251D0 (en) Imaging compounds
GB0821431D0 (en) Imaging compounds
GB0803455D0 (en) Imaging compounds